Fasching; Bernhard
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fasching; Bernhard.The latest application filed is for "isoindolinone compounds".
- Fasching; Bernhard - Basel CH
- FASCHING; Bernhard - Saint-Louis FR
| Patent | Date |
|---|---|
| Isoindolinone Compounds App 20220242846 - Flohr; Alexander ; et al. | 2022-08-04 |
| Compounds For Use As Therapeutically Active Substances In The Treatment And/or Prevention Of Neuroretinal Diseases App 20220089547 - STEGER; Matthias ; et al. | 2022-03-24 |
| N-(4-(oxazol-5-yl)phenyl) Chromane-3-carboxamide Derivatives And Related Compounds As Stimulators Of The Production Of Retinal Precursor Cells For The Treatment Of Neuroretinal Diseases App 20220089583 - STEGER; Matthias ; et al. | 2022-03-24 |
| Peptide macrocycles against Acinetobacter baumannii Grant 11,098,080 - Alanine , et al. August 24, 2 | 2021-08-24 |
| Isoxazolyl ether derivatives as GABA.sub.A .alpha.5 PAM Grant 11,091,471 - Buettelmann , et al. August 17, 2 | 2021-08-17 |
| Anti-bacterial peptide macrocycles and use thereof Grant 11,066,443 - Alanine , et al. July 20, 2 | 2021-07-20 |
| Compounds for use as therapeutically active substances in the treatment of retinal diseases Grant 10,807,973 - Steger , et al. October 20, 2 | 2020-10-20 |
| Compounds for use as therapeutically active substances in the treatment of retinal diseases Grant 10,752,593 - Steger , et al. A | 2020-08-25 |
| Compounds For Use As Therapeutically Active Substances In The Treatment Of Retinal Diseases App 20200207719 - STEGER; Matthias ; et al. | 2020-07-02 |
| Compounds For Use As Therapeutically Active Substances In The Treatment Of Retinal Diseases App 20200207749 - STEGER; Matthias ; et al. | 2020-07-02 |
| Spiro-oxazolones App 20200039997 - Runtz-Schmitt; Valerie ; et al. | 2020-02-06 |
| Anti-bacterial Peptide Macrocycles And Use Thereof App 20200040031 - Alanine; Alexander ; et al. | 2020-02-06 |
| Spiro-oxazolones Grant 10,479,796 - Runtz-Schmitt , et al. Nov | 2019-11-19 |
| Isoxazolyl Ether Derivatives As Gaba A Alpha5 Pam App 20190300516 - BUETTELMANN; Bernd ; et al. | 2019-10-03 |
| Peptide Macrocycles Against Acinetobacter Baumannii App 20180362578 - Alanine; Alexander ; et al. | 2018-12-20 |
| Spiro-thiazolones Grant 10,092,551 - Dolente , et al. October 9, 2 | 2018-10-09 |
| Peptide macrocycles against acinetobacter baumannii Grant 10,030,047 - Alanine , et al. July 24, 2 | 2018-07-24 |
| Spiro-oxazolones Grant 9,828,385 - Dolente , et al. November 28, 2 | 2017-11-28 |
| Spiro-thiazolones App 20170246153 - Dolente; Cosimo ; et al. | 2017-08-31 |
| Peptide Macrocycles Against Acinetobacter Baumannii App 20170233437 - Alanine; Alexander ; et al. | 2017-08-17 |
| Spiro-oxazolones App 20170008901 - Runtz-Schmitt; Valerie ; et al. | 2017-01-12 |
| Spiro-oxazolones App 20160355522 - Dolente; Cosimo ; et al. | 2016-12-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 